Background The impact of active cancer in COVID-19 patients is poorly defined; however,
most studies showed a poorer outcome in cancer patients compared to the general …

PURPOSE Whether cancer is associated with worse prognosis among patients with COVID-
19 is unknown. We aimed to quantify the effect (if any) of the presence as opposed to …

Background The aim of the study was to compare coronavirus disease 2019 (COVID-19)
severity presentation between oncologic and non-oncologic patients and to evaluate the …

Background The COVID-19 has caused significant mortality and morbidity across the globe.
Patients with cancer are especially vulnerable given their immunocompromised state. We …

PURPOSE SARS-CoV-2 (COVID-19) is a systemic infection. Patients with cancer are
immunocompromised and may be vulnerable to COVID-related morbidity and mortality. The …

Background The COVID-19 pandemic remains a pressing concern to patients with cancer as
countries enter the second peak of the pandemic and beyond. It remains unclear whether …

Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …

Background Cancer seems to have an independent adverse prognostic effect on COVID-19-
related mortality, but uncertainty exists regarding its effect across different patient subgroups …

Background Complications in cancer patients with coronavirus disease 2019 (COVID-19)
have not been examined. This analysis aimed to compare characteristics of COVID-19 …

We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in
Europe from the retrospective, multi-center observational OnCovid study. We identified 204 …